Nature Medicine

, volume 26 , issue 9 , pages 1422-1427

Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

Seth J. Zost ¹

Pavlo Gilchuk ¹

Rita E. Chen ^{2, 3}

James Brett Case ³

Joseph X Reidy ¹

Andrew Trivette ¹

Rachel S. Nargi ¹

Rachel E. Sutton ¹

Naveenchandra Suryadevara ¹

Elaine C. Chen ⁴

Elad Binshtein ¹

Swathi Shrihari ³

Mario Ostrowski ⁵

Helen Y. Chu ⁶

Jonathan E. Didier ⁷

Keith W MacRenaris ⁷

Taylor Jones ¹

Samuel Day ¹

Luke Myers ¹

F. Eun-Hyung Lee ⁸

Doan C. Nguyen ⁸

Ignacio Sanz ⁸

David R. Martinez ⁹

Paul W Rothlauf ^{10, 11}

Louis Marie Bloyet ¹¹

Sean Whelan ^{10, 11}

Ralph S Baric ⁹

Larissa B Thackray ³

Michael S. Diamond ^{2, 3, 11, 12}

Robert H. Carnahan ^{1, 13}

James Crowe ^{1, 4, 13}

Hide authors affiliations Show authors affiliations: 13 affiliations

Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, USA |

Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, USA |

Department of Medicine, Washington University School of Medicine, St. Louis, USA |

⁴

Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, USA |

⁵

Department of Medicine, University of Toronto, Toronto, CANADA |

⁶

Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA |

⁷

Berkeley Lights, Inc., Emeryville, USA |

⁸

Department of Medicine, Emory University, Atlanta, USA |

⁹

Department of Epidemiology, University of North Carolina At Chapel Hill, Chapel Hill, USA |

¹⁰

Program in Virology, Harvard Medical School, Boston, USA |

¹¹

Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, USA |

¹²

Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA |

¹³

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, USA |

Publication type: Journal Article

Publication date: 2020-07-10

Springer Nature

Nature Medicine

scimago Q1

wos Q1

SJR: 18.333

CiteScore: 82.4

Impact factor: 50.0

ISSN: 10788956, 1546170X, 17447933

DOI: 10.1038/s41591-020-0998-x

Copy DOI

PubMed ID: 32651581

General Biochemistry, Genetics and Molecular Biology

General Medicine

Abstract

Antibodies are a principal determinant of immunity for most RNA viruses and have promise to reduce infection or disease during major epidemics. The novel coronavirus SARS-CoV-2 has caused a global pandemic with millions of infections and hundreds of thousands of deaths to date1,2. In response, we used a rapid antibody discovery platform to isolate hundreds of human monoclonal antibodies (mAbs) against the SARS-CoV-2 spike (S) protein. We stratify these mAbs into five major classes on the basis of their reactivity to subdomains of S protein as well as their cross-reactivity to SARS-CoV. Many of these mAbs inhibit infection of authentic SARS-CoV-2 virus, with most neutralizing mAbs recognizing the receptor-binding domain (RBD) of S. This work defines sites of vulnerability on SARS-CoV-2 S and demonstrates the speed and robustness of advanced antibody discovery platforms. A platform for rapid antibody discovery enabled the isolation of hundreds of human monoclonal antibodies against SARS-CoV-2 and the prioritization of potent antibody candidates for clinical trials in patients with COVID-19.

Found

2 citations

Yusubalieva Gaukhar

🥼 🤝

PhD in Health sciences

84 publications, 930 citations

h-index: 16

Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences

Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency of Russia

Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies, FMBA of Russia

Research interests

Brain stem cells

CAR-NK cells

Experimental oncology

Immunotherapy

Oncolytic viruses

1 citation

Ivanov Aleksandr

DSc in Biological/biomedical sciences

143 publications, 3 066 citations, 13 reviews

h-index: 25

Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences

Research interests

HIV

Reactive oxygen species

1 citation

Lockhart Stephen

26 publications, 19 390 citations, 4 reviews

h-index: 17

Top-30

Journals

	5 10 15 20 25 30 35 40
bioRxiv	bioRxiv, 39, 8.55% bioRxiv 39 publications, 8.55%
Cell Reports	Cell Reports, 23, 5.04% Cell Reports 23 publications, 5.04%
Frontiers in Immunology	Frontiers in Immunology, 14, 3.07% Frontiers in Immunology 14 publications, 3.07%
Cell	Cell, 11, 2.41% Cell 11 publications, 2.41%
Nature Communications	Nature Communications, 10, 2.19% Nature Communications 10 publications, 2.19%
Immunity	Immunity, 10, 2.19% Immunity 10 publications, 2.19%
Nature	Nature, 9, 1.97% Nature 9 publications, 1.97%
iScience	iScience, 9, 1.97% iScience 9 publications, 1.97%
Cell Host and Microbe	Cell Host and Microbe, 7, 1.54% Cell Host and Microbe 7 publications, 1.54%
Science	Science, 6, 1.32% Science 6 publications, 1.32%
medRxiv : the preprint server for health sciences	medRxiv : the preprint server for health sciences, 6, 1.32% medRxiv : the preprint server for health sciences 6 publications, 1.32%
Journal of Clinical Investigation	Journal of Clinical Investigation, 5, 1.1% Journal of Clinical Investigation 5 publications, 1.1%
Viruses	Viruses, 5, 1.1% Viruses 5 publications, 1.1%
Vaccines	Vaccines, 5, 1.1% Vaccines 5 publications, 1.1%
mAbs	mAbs, 5, 1.1% mAbs 5 publications, 1.1%
Science Translational Medicine	Science Translational Medicine, 4, 0.88% Science Translational Medicine 4 publications, 0.88%
Communications Biology	Communications Biology, 4, 0.88% Communications Biology 4 publications, 0.88%
Signal Transduction and Targeted Therapy	Signal Transduction and Targeted Therapy, 4, 0.88% Signal Transduction and Targeted Therapy 4 publications, 0.88%
Scientific Reports	Scientific Reports, 3, 0.66% Scientific Reports 3 publications, 0.66%
International Journal of Molecular Sciences	International Journal of Molecular Sciences, 3, 0.66% International Journal of Molecular Sciences 3 publications, 0.66%
Frontiers in Microbiology	Frontiers in Microbiology, 3, 0.66% Frontiers in Microbiology 3 publications, 0.66%
Journal of Biomedical Science	Journal of Biomedical Science, 3, 0.66% Journal of Biomedical Science 3 publications, 0.66%
PLoS Pathogens	PLoS Pathogens, 3, 0.66% PLoS Pathogens 3 publications, 0.66%
PLoS ONE	PLoS ONE, 3, 0.66% PLoS ONE 3 publications, 0.66%
Journal of Virology	Journal of Virology, 3, 0.66% Journal of Virology 3 publications, 0.66%
Proceedings of the National Academy of Sciences of the United States of America	Proceedings of the National Academy of Sciences of the United States of America, 3, 0.66% Proceedings of the National Academy of Sciences of the United States of America 3 publications, 0.66%
Journal of Experimental Medicine	Journal of Experimental Medicine, 3, 0.66% Journal of Experimental Medicine 3 publications, 0.66%
Biomedicines	Biomedicines, 2, 0.44% Biomedicines 2 publications, 0.44%
Pharmaceutics	Pharmaceutics, 2, 0.44% Pharmaceutics 2 publications, 0.44%
	5 10 15 20 25 30 35 40

Publishers

	20 40 60 80 100 120
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 109, 23.9% Cold Spring Harbor Laboratory 109 publications, 23.9%
Elsevier	Elsevier, 107, 23.46% Elsevier 107 publications, 23.46%
Springer Nature	Springer Nature, 73, 16.01% Springer Nature 73 publications, 16.01%
MDPI	MDPI, 25, 5.48% MDPI 25 publications, 5.48%
Frontiers Media S.A.	Frontiers Media S.A., 24, 5.26% Frontiers Media S.A. 24 publications, 5.26%
American Association for the Advancement of Science (AAAS)	American Association for the Advancement of Science (AAAS), 14, 3.07% American Association for the Advancement of Science (AAAS) 14 publications, 3.07%
Wiley	Wiley, 14, 3.07% Wiley 14 publications, 3.07%
Taylor & Francis	Taylor & Francis, 11, 2.41% Taylor & Francis 11 publications, 2.41%
Oxford University Press	Oxford University Press, 11, 2.41% Oxford University Press 11 publications, 2.41%
Public Library of Science (PLoS)	Public Library of Science (PLoS), 10, 2.19% Public Library of Science (PLoS) 10 publications, 2.19%
American Chemical Society (ACS)	American Chemical Society (ACS), 8, 1.75% American Chemical Society (ACS) 8 publications, 1.75%
American Society for Microbiology	American Society for Microbiology, 8, 1.75% American Society for Microbiology 8 publications, 1.75%
American Society for Clinical Investigation	American Society for Clinical Investigation, 6, 1.32% American Society for Clinical Investigation 6 publications, 1.32%
Mary Ann Liebert	Mary Ann Liebert, 4, 0.88% Mary Ann Liebert 4 publications, 0.88%
Royal Society of Chemistry (RSC)	Royal Society of Chemistry (RSC), 3, 0.66% Royal Society of Chemistry (RSC) 3 publications, 0.66%
Proceedings of the National Academy of Sciences (PNAS)	Proceedings of the National Academy of Sciences (PNAS), 3, 0.66% Proceedings of the National Academy of Sciences (PNAS) 3 publications, 0.66%
Rockefeller University Press	Rockefeller University Press, 3, 0.66% Rockefeller University Press 3 publications, 0.66%
Annual Reviews	Annual Reviews, 3, 0.66% Annual Reviews 3 publications, 0.66%
Ovid Technologies (Wolters Kluwer Health)	Ovid Technologies (Wolters Kluwer Health), 2, 0.44% Ovid Technologies (Wolters Kluwer Health) 2 publications, 0.44%
The American Association of Immunologists	The American Association of Immunologists, 1, 0.22% The American Association of Immunologists 1 publication, 0.22%
Massachusetts Medical Society	Massachusetts Medical Society, 1, 0.22% Massachusetts Medical Society 1 publication, 0.22%
Social Science Electronic Publishing	Social Science Electronic Publishing, 1, 0.22% Social Science Electronic Publishing 1 publication, 0.22%
European Molecular Biology Organization	European Molecular Biology Organization, 1, 0.22% European Molecular Biology Organization 1 publication, 0.22%
Institute of Electrical and Electronics Engineers (IEEE)	Institute of Electrical and Electronics Engineers (IEEE), 1, 0.22% Institute of Electrical and Electronics Engineers (IEEE) 1 publication, 0.22%
eLife Sciences Publications	eLife Sciences Publications, 1, 0.22% eLife Sciences Publications 1 publication, 0.22%
Pleiades Publishing	Pleiades Publishing, 1, 0.22% Pleiades Publishing 1 publication, 0.22%
Mediar Press	Mediar Press, 1, 0.22% Mediar Press 1 publication, 0.22%
AME Publishing Company	AME Publishing Company, 1, 0.22% AME Publishing Company 1 publication, 0.22%
Microbiology Society	Microbiology Society, 1, 0.22% Microbiology Society 1 publication, 0.22%
	20 40 60 80 100 120

We do not take into account publications without a DOI.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

457

Cite this

GOST |

Cite this

GOST Copy

Zost S. J. et al. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein // Nature Medicine. 2020. Vol. 26. No. 9. pp. 1422-1427.

GOST all authors (up to 50) Copy

Zost S. J., Gilchuk P., Chen R. E., Case J. B., Reidy J. X., Trivette A., Nargi R. S., Sutton R. E., Suryadevara N., Chen E. C., Binshtein E., Shrihari S., Ostrowski M., Chu H. Y., Didier J. E., MacRenaris K. W., Jones T., Day S., Myers L., Lee F. E., Nguyen D. C., Sanz I., Martinez D. R., Rothlauf P. W., Bloyet L. M., Whelan S., Baric R. S., Thackray L. B., Diamond M., Carnahan R. H., Crowe J. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein // Nature Medicine. 2020. Vol. 26. No. 9. pp. 1422-1427.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.1038/s41591-020-0998-x

UR - https://doi.org/10.1038/s41591-020-0998-x

TI - Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

T2 - Nature Medicine

AU - Zost, Seth J.

AU - Gilchuk, Pavlo

AU - Chen, Rita E.

AU - Case, James Brett

AU - Reidy, Joseph X

AU - Trivette, Andrew

AU - Nargi, Rachel S.

AU - Sutton, Rachel E.

AU - Suryadevara, Naveenchandra

AU - Chen, Elaine C.

AU - Binshtein, Elad

AU - Shrihari, Swathi

AU - Ostrowski, Mario

AU - Chu, Helen Y.

AU - Didier, Jonathan E.

AU - MacRenaris, Keith W

AU - Jones, Taylor

AU - Day, Samuel

AU - Myers, Luke

AU - Lee, F. Eun-Hyung

AU - Nguyen, Doan C.

AU - Sanz, Ignacio

AU - Martinez, David R.

AU - Rothlauf, Paul W

AU - Bloyet, Louis Marie

AU - Whelan, Sean

AU - Baric, Ralph S

AU - Thackray, Larissa B

AU - Diamond, Michael S.

AU - Carnahan, Robert H.

AU - Crowe, James

PY - 2020

DA - 2020/07/10

PB - Springer Nature

SP - 1422-1427

IS - 9

VL - 26

PMID - 32651581

SN - 1078-8956

SN - 1546-170X

SN - 1744-7933

ER -

BibTex |

Cite this

BibTex (up to 50 authors) Copy

@article{2020_Zost,

author = {Seth J. Zost and Pavlo Gilchuk and Rita E. Chen and James Brett Case and Joseph X Reidy and Andrew Trivette and Rachel S. Nargi and Rachel E. Sutton and Naveenchandra Suryadevara and Elaine C. Chen and Elad Binshtein and Swathi Shrihari and Mario Ostrowski and Helen Y. Chu and Jonathan E. Didier and Keith W MacRenaris and Taylor Jones and Samuel Day and Luke Myers and F. Eun-Hyung Lee and Doan C. Nguyen and Ignacio Sanz and David R. Martinez and Paul W Rothlauf and Louis Marie Bloyet and Sean Whelan and Ralph S Baric and Larissa B Thackray and Michael S. Diamond and Robert H. Carnahan and James Crowe},

title = {Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein},

journal = {Nature Medicine},

year = {2020},

volume = {26},

publisher = {Springer Nature},

month = {jul},

url = {https://doi.org/10.1038/s41591-020-0998-x},

number = {9},

pages = {1422--1427},

doi = {10.1038/s41591-020-0998-x}

}

MLA

Cite this

MLA Copy

Zost, Seth J., et al. “Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein.” Nature Medicine, vol. 26, no. 9, Jul. 2020, pp. 1422-1427. https://doi.org/10.1038/s41591-020-0998-x.

Publisher

Springer Nature

Journal

Nature Medicine

scimago Q1

wos Q1

SJR

18.333

CiteScore

82.4

Impact factor

50.0

ISSN

10788956 (Print)

1546170X (Electronic)

17447933 (Electronic)